Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2000 1
2002 2
2004 3
2005 5
2006 5
2007 1
2008 1
2009 2
2010 4
2011 3
2012 6
2013 12
2014 5
2015 11
2016 13
2017 5
2018 2
2020 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 28133686

72 results

Results by year

Filters applied: . Clear all
Page 1
The Neutrophil-to-Lymphocyte Ratio Predicts All-Cause Mortality in Patients with Implantable Cardioverter Defibrillators.
Hashimoto N, Arimoto T, Narumi T, Iwayama T, Kutsuzawa D, Ishigaki D, Kumagai YU, Tamura H, Nishiyama S, Takahashi H, Shishido T, Miyamoto T, Watanabe T, Kubota I. Hashimoto N, et al. Pacing Clin Electrophysiol. 2017 Feb;40(2):135-144. doi: 10.1111/pace.13003. Epub 2017 Jan 18. Pacing Clin Electrophysiol. 2017. PMID: 27996101 Clinical Trial.
Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation.
Gatzoulis KA, Vouliotis AI, Tsiachris D, Salourou M, Archontakis S, Dilaveris P, Gialernios T, Arsenos P, Karystinos G, Sideris S, Kallikazaros I, Stefanadis C. Gatzoulis KA, et al. Circ Arrhythm Electrophysiol. 2013 Jun;6(3):504-12. doi: 10.1161/CIRCEP.113.000216. Epub 2013 Apr 15. Circ Arrhythm Electrophysiol. 2013. PMID: 23588627
Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention.
Bhonsale A, James CA, Tichnell C, Murray B, Gagarin D, Philips B, Dalal D, Tedford R, Russell SD, Abraham T, Tandri H, Judge DP, Calkins H. Bhonsale A, et al. J Am Coll Cardiol. 2011 Sep 27;58(14):1485-96. doi: 10.1016/j.jacc.2011.06.043. J Am Coll Cardiol. 2011. PMID: 21939834 Free article.
72 results